PURPOSE: Many studies have evaluated the associations between pre-diagnostic circulating C-reactive protein (CRP), interleukin-6 (IL-6) and colorectal cancer risk, but their results are inconsistent. We therefore conducted a meta-analysis to investigate these associations. METHODS: A comprehensive literature search up to October 2013 was undertaken in PubMed. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were used to calculate estimated effect. RESULTS: Eighteen studies on CRP comprising a total of 4,706 colorectal cancer cases were included in this meta-analysis. The summary RR of colorectal cancer for one unit change in natural logarithm (ln) CRP was 1.12 [95% CI (1.05-1.21)]. There was statistically significant heterogeneity among studies (p = 0.006; I (2) = 51.7%). After excluding the studies contributing most to the heterogeneity, summary estimate was essentially unchanged. In addition, the association was significant for colon cancer [RR = 1.13, 95 % CI (1.05-1.21)], not for rectal cancer [RR = 1.03, 95% CI (0.90-1.17)]. We also found that CRP was significantly associated with increased risk of colorectal cancer among men, but not among women. There were six studies on IL-6 that involved a total of 1,068 colorectal cancer cases. The pooled RR of colorectal cancer for one unit change in ln IL-6 was 1.10 (95% CI 0.88-1.36), and no statistically significant heterogeneity was found (p = 0.175; I(2) = 34.8%). CONCLUSION: Our results suggest that pre-diagnostic circulating CRP is associated with increased risk of colorectal cancer. However, there is no significant association between IL-6 and colorectal cancer risk.
PURPOSE: Many studies have evaluated the associations between pre-diagnostic circulating C-reactive protein (CRP), interleukin-6 (IL-6) and colorectal cancer risk, but their results are inconsistent. We therefore conducted a meta-analysis to investigate these associations. METHODS: A comprehensive literature search up to October 2013 was undertaken in PubMed. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were used to calculate estimated effect. RESULTS: Eighteen studies on CRP comprising a total of 4,706 colorectal cancer cases were included in this meta-analysis. The summary RR of colorectal cancer for one unit change in natural logarithm (ln) CRP was 1.12 [95% CI (1.05-1.21)]. There was statistically significant heterogeneity among studies (p = 0.006; I (2) = 51.7%). After excluding the studies contributing most to the heterogeneity, summary estimate was essentially unchanged. In addition, the association was significant for colon cancer [RR = 1.13, 95 % CI (1.05-1.21)], not for rectal cancer [RR = 1.03, 95% CI (0.90-1.17)]. We also found that CRP was significantly associated with increased risk of colorectal cancer among men, but not among women. There were six studies on IL-6 that involved a total of 1,068 colorectal cancer cases. The pooled RR of colorectal cancer for one unit change in ln IL-6 was 1.10 (95% CI 0.88-1.36), and no statistically significant heterogeneity was found (p = 0.175; I(2) = 34.8%). CONCLUSION: Our results suggest that pre-diagnostic circulating CRP is associated with increased risk of colorectal cancer. However, there is no significant association between IL-6 and colorectal cancer risk.
Authors: Mingyang Song; Raaj S Mehta; Kana Wu; Charles S Fuchs; Shuji Ogino; Edward L Giovannucci; Andrew T Chan Journal: Cancer Prev Res (Phila) Date: 2015-10-28
Authors: Michael D Wirth; Angela Jessup; Gabrielle Turner-McGrievy; Nitin Shivappa; Thomas G Hurley; James R Hébert Journal: Sleep Date: 2020-11-12 Impact factor: 5.849
Authors: Wen-Yi Huang; Sonja I Berndt; Meredith S Shiels; Hormuzd A Katki; Anil K Chaturvedi; Nicolas Wentzensen; Britton Trabert; Troy J Kemp; Ligia A Pinto; Allan Hildesheim; Nathaniel Rothman; Mark P Purdue Journal: Carcinogenesis Date: 2019-07-06 Impact factor: 4.944
Authors: Artemisia Kakourou; Charalampia Koutsioumpa; David S Lopez; Judith Hoffman-Bolton; Gary Bradwin; Nader Rifai; Kathy J Helzlsouer; Elizabeth A Platz; Konstantinos K Tsilidis Journal: Cancer Causes Control Date: 2015-07-29 Impact factor: 2.506
Authors: Chul Kim; Xuehong Zhang; Andrew T Chan; Howard D Sesso; Nader Rifai; Meir J Stampfer; Jing Ma Journal: Cancer Epidemiol Date: 2016-08-06 Impact factor: 2.984